(14:19 GMT) Edgewise Therapeutics Price Target Raised to $51.00/Share From $41.00 by Guggenheim
Dow Jones Newswires
Edgewise Therapeutics Is Maintained at Buy by Guggenheim
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:EWTX
- Language
- English